Latest 8-K filings
NASDAQ
Target Hospitality Corp. announced the appointment of Margaret (Peggy) Smyth and Erich Sanchack as independent directors to its Board, effective August 4, 2026, to enhance strategic expertise.
NASDAQ
Eos Energy Enterprises reported a substantial year-over-year revenue increase for Q2 2026, alongside a record backlog, but also announced a tightened full-year revenue outlook and a significant net loss.
NYSE
ADNT
Adient PLCAdient plc reported third quarter 2026 financial results showing increased net sales but a decrease in net income and diluted earnings per share compared to the prior year.
NYSE
Kontoor Brands is divesting its global Lee business to ABG-Storm LLC, a move expected to streamline operations and financial reporting.
NYSE
Capri Holdings announced first quarter Fiscal 2027 results with revenue down 3.5% but EPS and operating income exceeding expectations, while maintaining full-year EPS guidance.
NYSE
MTRN
Materion CORPMaterion Corporation announced record-breaking second-quarter 2026 financial results, including record net sales, value-added sales, adjusted EBITDA, and adjusted EPS, leading to an increased full-year earnings per share outlook.
NYSE
Iron Mountain Inc. announced record-breaking second quarter 2026 results, exceeding expectations with significant year-over-year revenue growth and increased full-year financial guidance.
NYSE
Chimera Investment Corporation announced the declaration of its third quarter 2026 cash dividends for its Series A, B, C, and D preferred stocks.
NYSE
Chimera Investment Corporation announced its second quarter 2026 financial results, reporting earnings available for distribution of $0.46 per diluted common share, which supports its $0.45 quarterly dividend.
NYSE
COR
Cencora, INCCencora, Inc. has amended and restated its multi-currency revolving credit facility, increasing the aggregate commitment to $7.0 billion and extending the maturity date to July 2031.
NYSE
Kennametal Inc. announced robust fiscal 2026 fourth quarter and full-year results, showcasing substantial sales growth and record adjusted EPS, with a positive outlook for fiscal 2027.
NASDAQ
FTCI
Ftc Solar, INCFTC Solar announced a $20 million equity line of credit with Lincoln Park Capital and reported a 52% sequential revenue increase for Q2 2026, exceeding targets.
NYSE
Cardinal Health announces the appointment of Anita Zielinski as Chief Accounting Officer, effective November 5, 2026, succeeding Mary Scherer.
NYSE
PRGO
Perrigo CO PLCPerrigo Company plc announced its second quarter 2026 financial results, reporting a decrease in net sales and adjusted diluted EPS, while reaffirming its full-year outlook.
NYSE
NiSource Inc. reported second quarter 2026 results, reaffirming its full-year non-GAAP EPS guidance and long-term growth targets, while advancing its capital investment plan and customer savings initiatives.
NYSE
Delek Logistics Partners, LP announced its second quarter 2026 financial results, highlighting net income of $28.9 million and adjusted EBITDA of $143.5 million, while reaffirming full-year EBITDA guidance.
NYSE
Delek US Holdings announced robust second quarter 2026 financial results, showcasing significant net income and adjusted EBITDA growth, alongside strategic debt refinancing and shareholder returns.
NASDAQ
FRPT
Freshpet, INCFreshpet, Inc. announced robust second quarter 2026 financial results, showcasing significant net sales growth, improved gross margins, and an optimistic revised outlook for the full year.
NASDAQ
United Therapeutics reported a 2% revenue decrease to $783.3 million for Q2 2026, but saw net income rise 8% to $333.0 million, driven by strong EPS growth and strategic advancements in rare disease treatments and organ manufacturing.
NYSE
COR
Cencora, INCCencora announced robust third-quarter fiscal 2026 results, featuring a 5.1% year-over-year revenue increase to $84.8 billion and a 12.0% rise in adjusted diluted EPS to $4.48, leading to an upward revision of full-year EPS guidance.
NYSE
Dynatrace announced exceptional first quarter fiscal year 2027 financial results, exceeding high-end guidance for all metrics, driven by 17% ARR growth and significant new logo acquisition.
NYSE
CVS Health announced robust second quarter 2026 results, with total revenues up 7.3% year-over-year to $106.1 billion, and raised its full-year guidance for EPS and cash flow.
NASDAQ
Bloomin Brands reported strong Q2 2026 financial results, including a 1.3% increase in total revenues and raised full-year diluted EPS guidance.
NYSE
NCR Voyix reported second quarter 2026 results with a 21% revenue decline, primarily due to its hardware business transition, though adjusted EBITDA and recurring revenue showed growth.
NASDAQ
Recursion Pharmaceuticals announced strong pipeline execution and platform advancements in Q2 2026, highlighted by Genentech exercising an option for a neuroscience target and positive clinical updates for REC-4881 and REC-7735.
NASDAQ
Compass Pathways reports strong Q2 2026 results with its COMP360 psilocybin therapy showing significant progress towards regulatory approval and a robust cash reserve extending into 2028.
NYSE
Utz Brands announced its second quarter 2026 financial results, showing modest net sales growth and improved adjusted metrics, while also confirming a definitive agreement to be acquired by Intersnack Group.
NYSE
The Walt Disney Company announced robust fiscal Q3 results, with revenues up 7% and total segment operating income up 21%, driven by strong performance in Experiences and Entertainment, while reiterating full-year outlook and increasing share repurchase target.
NYSE
NATL
Ncr Atleos CORPNCR Atleos announced robust second quarter 2026 financial results, including a 67% increase in net income and a 25% rise in Adjusted EBITDA, while also anticipating an accelerated timeline for its merger with The Brinks Company.
PX
P10, INCRidgepost Capital announced robust second quarter 2026 financial results, surpassing $50 billion in AUM and declaring a quarterly cash dividend.